SciELO - Scientific Electronic Library Online

 
vol.65 issue3Estudio por manometría esofágica de pacientes con enfermedad por reflujo gastroesofágico, en CubaRespuesta a la terapia combinada vs monoterapia con betabloqueantes en profilaxis primaria de sangrado variceal en pacientes con cirrosis hepática author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Gen

Print version ISSN 0016-3503On-line version ISSN 2477-975X

Abstract

CASTILLO, R et al. Helicobacter pylori: Efectividad del tratamiento secuencial vs tratamiento convencional. Gen [online]. 2011, vol.65, n.3, pp.183-186. ISSN 0016-3503.

Helicobacter pylori (Helicobacter p. ) Its a bacteria that lives in the gastric mucosa and its prevalence is variable and it is associated to the development of peptic ulcer, lymphoma, and gastric cancer. Approximately 40% of individuals in developed countries are affected and 85% in undeveloped countries in which are related to low socioeconomics level. Recently its been proposed the use of a sequential therapy to eradicate the infection by Helicobacter p. The objective of this study consist in to compare the effectiveness between both treatments (Sequential and conventional) in the consult from the Gastroenterology Service of the Carlos J. Bello Hospital in a period of time between February 2008 to October 2009 in a total of 83 patients, 77,1% feminine, 22,9% masculine. The group that received conventional treatment represented 57,83% and sequential 42,17%. In regard to the effectiveness the conventional group presented 46, 99% and sequential group 32, 53%. The X2 test it didn’t present significative difference of effectiveness between both treatments.

Keywords : Helicobacter pylori; Conventional; Treatments; Sequential Treatments.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License